These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22609424)

  • 21. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
    Leyvraz C; Suter M; Verdumo C; Calmes JM; Paroz A; Darimont C; Gaillard RC; Pralong FP; Giusti V
    Diabetes Obes Metab; 2010 Mar; 12(3):195-203. PubMed ID: 19895635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor γ is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress.
    Yang Y; Qin X; Liu S; Li J; Zhu X; Gao T; Wang X
    J Neurochem; 2011 Aug; 118(3):429-39. PubMed ID: 21605119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ.
    Tiyerili V; Müller CF; Fung S; Panek D; Nickenig G; Becher UM
    J Mol Cell Cardiol; 2012 Aug; 53(2):268-76. PubMed ID: 22634137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia.
    Izawa Y; Takahashi S; Suzuki N
    Brain Res; 2009 Dec; 1305():64-73. PubMed ID: 19800324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.
    Fuenzalida K; Quintanilla R; Ramos P; Piderit D; Fuentealba RA; Martinez G; Inestrosa NC; Bronfman M
    J Biol Chem; 2007 Dec; 282(51):37006-15. PubMed ID: 17965419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
    Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
    Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
    Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells.
    Hovsepian E; Penas F; Goren NB
    Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
    Pesant M; Sueur S; Dutartre P; Tallandier M; Grimaldi PA; Rochette L; Connat JL
    Cardiovasc Res; 2006 Feb; 69(2):440-9. PubMed ID: 16337160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist.
    Sivarajah A; McDonald MC; Thiemermann C
    J Pharmacol Exp Ther; 2005 May; 313(2):896-901. PubMed ID: 15734901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
    Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
    Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism.
    Cantini G; Lombardi A; Borgogni E; Francalanci M; Ceni E; Degl'Innocenti S; Gelmini S; Poli G; Galli A; Serio M; Forti G; Luconi M
    Eur J Cell Biol; 2010 Sep; 89(9):645-53. PubMed ID: 20537761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.